Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma

CD4 + T cells support polyfunctionality of cytotoxic CD8 + T cells with memory potential in immunological control of tumor

(2020) Naoko Imai et al.   CANCER SCIENCE

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis

(2019) Lin Tuo et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma

(2019) Zeli Yin et al.   Journal of Hematology & Oncology

Macrophages and hepatocellular carcinoma

(2019) Zhiqiang Tian et al.   Cell and Bioscience

Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas

(2019) Yi-Wen Hsiao et al.   Genes

Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ

(2018) Mei Han et al.   BIOMEDICINE & PHARMACOTHERAPY

Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population

(2018) Suhg Namgoong et al.   LIVER INTERNATIONAL

MDSC; the Most Important Cell You Have Never Heard Of

(2018) R.J. Tesi   TRENDS IN PHARMACOLOGICAL SCIENCES

Role of exosomes in treatment of hepatocellular carcinoma

(2017) Demetrios Moris et al.   SURGICAL ONCOLOGY-OXFORD

Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1

(2016) Hyang Sook Seol et al.   CANCER LETTERS

Recurrence of Hepatocellular Cancer After Resection

(2015) Parissa Tabrizian et al.   ANNALS OF SURGERY

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma

(2015) Marta Garnelo et al.   GUT

Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma

(2015) Oscar W.H. Yeung et al.   JOURNAL OF HEPATOLOGY

Macrophages and cancer: from mechanisms to therapeutic implications

(2015) Renato Ostuni et al.   TRENDS IN IMMUNOLOGY

Influence of the C5a–C5a receptor system on breast cancer progression and patient prognosis

(2015) Takahisa Imamura et al.   Breast Cancer

STAMP: statistical analysis of taxonomic and functional profiles

(2014) Donovan H. Parks et al.   BIOINFORMATICS

Complement component 3 is a prognostic factor of non-small cell lung cancer

(2014) KAILONG LIN et al.   Molecular Medicine Reports

Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis

(2014) Hong-Qiang Zhao   WORLD JOURNAL OF GASTROENTEROLOGY

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Impairment of CD4+cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma

(2012) Junliang Fu et al.   HEPATOLOGY

Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression

(2012) Leticia Corrales et al.   JOURNAL OF IMMUNOLOGY

Opposing Roles for Complement Component C5a in Tumor Progression and the Tumor Microenvironment

(2012) L. Gunn et al.   JOURNAL OF IMMUNOLOGY

Photodynamic therapy boosts anti-glioma immunity in mice: A dependence on the activities of T cells and complement C3

(2011) Fei Li et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

(2010) Robert J. Clifford et al.   HEPATOLOGY

Complement: a key system for immune surveillance and homeostasis

(2010) Daniel Ricklin et al.   NATURE IMMUNOLOGY